PAFAH1B3 Predicts Poor Prognosis and Promotes Progression in Lung Adenocarcinoma

Scientists indicated that platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3), a prognostic risk factor, promoted proliferation, invasion and epithelial-to-mesenchymal transition and affectrf immune infiltrates in lung adenocarcinoma.